DE2759166A1 - Grease-based suppositories prodn. for rectal or vaginal admin. - comprises dispersing gelatin-encapsulated drugs in base contained in mould prior to its hardening - Google Patents

Grease-based suppositories prodn. for rectal or vaginal admin. - comprises dispersing gelatin-encapsulated drugs in base contained in mould prior to its hardening

Info

Publication number
DE2759166A1
DE2759166A1 DE19772759166 DE2759166A DE2759166A1 DE 2759166 A1 DE2759166 A1 DE 2759166A1 DE 19772759166 DE19772759166 DE 19772759166 DE 2759166 A DE2759166 A DE 2759166A DE 2759166 A1 DE2759166 A1 DE 2759166A1
Authority
DE
Germany
Prior art keywords
rectal
vaginal
admin
grease
hardening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19772759166
Other languages
German (de)
Inventor
Theodor Prof Dr Eckert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19772759166 priority Critical patent/DE2759166A1/en
Publication of DE2759166A1 publication Critical patent/DE2759166A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/08Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of suppositories or sticks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • A61K9/025Suppositories; Bougies; Bases therefor; Ovules characterised by shape or structure, e.g. hollow layered, coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Pharmaceuticals which may be incompatible, with the grease base of a suppository, are encapsulated in gelatin prior to dispersion in the base. The base is contained in moulds and the capsules are dispersed therein before hardening. Used for rectal or vaginal admin.

Description

Verfahren zur IIerstellung von Suppositorien Method of making suppositories

zur rektalen oder vaginalen Applikation zur Vermeidung von Inkompatibilitäten der Wirkstoffe und zur Verbesserung der Resorption der wirkstoffe Die Erfindung betrifft ein Verfahren zur Herstellung von Suppositorien zur rektalen oder vaginalen Applikation zur Vermeidung von Inkompatibilitäten der Wirkstoffe und zur Verbesserung der Resorption der Wirkstoffe. Die rektale oder vaginale Applikation von Wirkstoffen erfolgt im allgemeinen in Form von Suppositorien, die auf der Grundlage von speziellen Fetten aufgebaut sind wie beispielsweise Hartfett D.A.B. 7, ein Gemisch von Triglyceriden der Fettsäuren C12 - C13 mit geringen Anteilen von Di- und Monoglyceriden. Es sind jedoch auch andere ähnliche fettartige Suppositorienmassen im Gebrauch. for rectal or vaginal application to avoid incompatibilities the active ingredients and to improve the absorption of the active ingredients The invention relates to a process for the preparation of suppositories for rectal or vaginal Application to avoid incompatibilities of the active ingredients and to improve the absorption of the active ingredients. The rectal or vaginal application of active ingredients is generally made in the form of suppositories made on the basis of special Fats are built up such as hard fat D.A.B. 7, a mixture of triglycerides of fatty acids C12 - C13 with small amounts of di- and monoglycerides. There are however, other similar fat-like suppository compositions are in use.

Die Herstellung solcher Arzneiformen erfolgt im allgemeinen in der Weise, daß die fettartigen Massen geschmolzen werden die Wirkstoffe in die geschmolzene Masse eingearbeitet werden und die Mischung schlieielich in geeignete Formen ausgegossen wird. Dieses Verfahren ist jedoch häufig durch zwei Faktoren eingeschränkt. Einmal kann es zd unerwünschten Reaktionen der Wirkstoffe untereinader bzw. Ft der Suppositorienmasse kommend So kann es beispielsweise zu einer Reaktion saurer Wirkstoffe mit dem Salz eines weniger sauren Wirkstoffs kommen.The production of such dosage forms is generally carried out in the Way that the fatty masses are melted the active ingredients in the melted Mass are incorporated and the mixture is finally poured into suitable molds will. However, this method is often limited by two factors. Once There may be undesirable reactions between the active ingredients or the suppository mass coming For example, acidic substances can react with the salt of a less acidic ingredient.

Es sind jedoch auch andere Inkompatibilitäten möglich. Zum anderen ist die Linarteitung von Wirkstoffen in fettartige Massen häufig, von Arzneistoff zu Arzneistoff unterschiedlich, für die rektale oder vaginale Resorption nicht optimal. Die Erfindung vermeidet diese Nachteile der gebräuchlichen auf Fettbasis beruhenden Guppositorienmassen.However, other incompatibilities are also possible. On the other hand the linear conduction of active substances into fat-like masses is common, of medicinal substance different to drug, not optimal for rectal or vaginal absorption. The invention avoids these disadvantages of the conventional fat-based ones Guppositories.

Die Erfindung besteht darin, daß beim AusgieXen der fettartigen Suppositorienmassen eine Gelatinekapsel in die noch flüssige Masse eingebettet wird, die einen Wirkstoff in fester oder gelöster Form enthält. Hierdurch wird einmal erreicht, daß es infolge der räumlichen Trennung nicht zu unerwünschten Reaktionen zwischen den Wirkstoffen des Arzneistoffträgers bzw. mit dem Arzneistoffträger selbst kommt. Zum anderen ist es auf diese Weise möglich, für jeden Wirkstoff den für seine Resorption jeweils besten Arzneistoffträger zu verwenden. So ist es beispielsweise möglich, in die fettartige Suppositorienmasse solche Wirkstoffe einzuarbeiten, die hieraus am besten resorbiert werden, in die Gelatinekapsel jedoch solche Wirkstoffe, deren Resorption am besten in fester Form oder in Form geeigneter Lösungen erfolgt.The invention consists in that when pouring out the fat-like suppository masses a gelatin capsule is embedded in the still liquid mass, which contains an active ingredient Contains in solid or dissolved form. This is achieved once that it as a result the spatial separation does not lead to undesirable reactions between the active ingredients of the drug carrier or with the drug carrier itself. On the other hand In this way it is possible for each active substance to determine its absorption best excipients to use. For example, it is possible to enter the fat-like suppository mass to incorporate such active ingredients that best from this are absorbed, in the gelatin capsule, however, such active substances, their absorption is best done in solid form or in the form of suitable solutions.

Die folgenden Beispiele erläutern die Erfindung: Beispiel 1 In eine gebräuchliche fettartige Suppositorienmasse wird ein beliebiger Arzneistoff mit saurem Charakter eingearbeitet und die Masse in Formen ausgegossen. Vor dem Erstarren der Suppositorienmasse wird eine Gelatinekapsel eingebettet, die mit dem Salz einer weniger sauren Säure gefüllt ist wie beispielsweise Theophyllin-Äthylendiamin oder Phenobarbital-Na.The following examples illustrate the invention: Example 1 In a common fat-like suppository mass is made with any drug acidic character incorporated and poured the mass into molds. Before solidifying the suppository mass is embedded in a gelatin capsule, which is filled with the salt less acidic acid such as theophylline ethylenediamine or Phenobarbital Na.

Beispiel 2 In eine gebräuchliche Suppositorienmasse auf Fettbasis wird ein beliebiger Arzneistoff eingearbeitet und die Masse in Formen ausgegossen. Vor dem Erstarren der Suppositorienmasse wird eine Gelatinekapsel eingebettet, die einen in Polyäthylenglykol gelösten Wirkstoff enthält.Example 2 In a conventional fat-based suppository mass any medicinal substance is incorporated and the mass is poured into molds. Before the suppository mass solidifies, a gelatin capsule is embedded which contains an active ingredient dissolved in polyethylene glycol.

Formelzusammenstellung Theophyllin-Äthylendiamin Phenobarbital-Na Composition of formulas theophylline-ethylenediamine Phenobarbital Na

Claims (1)

Patentansruch Verfahren zur Herstellung von Suppositorien auf Fettbasis zur rektalen oder vaginalen Applikation mit dem Ziel der Vermeidun von Inkompatibilitäten der wirkstoffe untereinander bzw. dem Wirkstoffträger und zur besseren Resorption der Wirkstoffe dadurch gekennzeichnet, daß in die in ihren Formen noch nicht erstarrten Suppositorienmassen Gelatinekapseln eingebettet werden, die mit festen oder gelösten Wirkstoffen gefüllt sind.Claim Process for the production of fat-based suppositories for rectal or vaginal application with the aim of avoiding incompatibilities the active ingredients with each other or the active ingredient carrier and for better absorption of the active ingredients characterized in that they have not yet solidified in their forms Suppository masses are embedded in gelatin capsules with solid or dissolved Active ingredients are filled.
DE19772759166 1977-12-31 1977-12-31 Grease-based suppositories prodn. for rectal or vaginal admin. - comprises dispersing gelatin-encapsulated drugs in base contained in mould prior to its hardening Pending DE2759166A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19772759166 DE2759166A1 (en) 1977-12-31 1977-12-31 Grease-based suppositories prodn. for rectal or vaginal admin. - comprises dispersing gelatin-encapsulated drugs in base contained in mould prior to its hardening

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772759166 DE2759166A1 (en) 1977-12-31 1977-12-31 Grease-based suppositories prodn. for rectal or vaginal admin. - comprises dispersing gelatin-encapsulated drugs in base contained in mould prior to its hardening

Publications (1)

Publication Number Publication Date
DE2759166A1 true DE2759166A1 (en) 1979-07-12

Family

ID=6027870

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772759166 Pending DE2759166A1 (en) 1977-12-31 1977-12-31 Grease-based suppositories prodn. for rectal or vaginal admin. - comprises dispersing gelatin-encapsulated drugs in base contained in mould prior to its hardening

Country Status (1)

Country Link
DE (1) DE2759166A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446149A (en) * 1981-12-14 1984-05-01 Kineshiro Nagai Medicine for treatment of cervical erosion
EP0240826A2 (en) * 1986-04-03 1987-10-14 Klocke, Hartmut Bait for animals

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446149A (en) * 1981-12-14 1984-05-01 Kineshiro Nagai Medicine for treatment of cervical erosion
EP0240826A2 (en) * 1986-04-03 1987-10-14 Klocke, Hartmut Bait for animals
EP0240826A3 (en) * 1986-04-03 1988-09-21 Klocke, Hartmut Bait for animals

Similar Documents

Publication Publication Date Title
DE68926432T2 (en) Solid encapsulated drug, method and device for its manufacture
DE2037947C3 (en) Encapsulated preparations
DE1127542B (en) Process for the production of medicinal pills for ruminants
DE2724239C2 (en)
DE1963081C3 (en) Process for the production of gelatin capsules
DE2045199B2 (en) Method of making a margarine
DE2759166A1 (en) Grease-based suppositories prodn. for rectal or vaginal admin. - comprises dispersing gelatin-encapsulated drugs in base contained in mould prior to its hardening
DE1766546C3 (en) Process for the production of solid drug preparations in the form of tablets or tablets
DE2838387C2 (en)
DE2161458A1 (en) Edible capsules
EP0166946B1 (en) Cosmetic product
DE858128C (en) Process for the production of a preparation containing at least two incompatible substances in the form of pills, suppositories and the like. like
DE3442065A1 (en) NIFEDIPINE COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF
DE667500C (en) Process for the production of base materials for medicinal substances to be introduced into body cavities
DE1617362A1 (en) Process for the production of medicaments with delayed release of active substances in the form of capsules
DE2219675C3 (en) Process for the preparation of a mixture of a finely crystallized fat and a powder
DE69534916T2 (en) NEW METHOD FOR MANUFACTURING SUPPOSITORIES
DE936228C (en) Process for the production of wax pastes
DE1097083B (en) Suppository mass
DE1145903B (en) Process for the production of high melting point fat particles suitable for mixing with basic feedstuffs
DE1078562B (en) Process for the production of solid fats from palm oil suitable for the preparation of margarine
AT153592B (en) Process for the production of shaped medicinal preparations.
DE1492847C (en) Process for the production of a chocolate product in the form of tiny spheres
DE671872C (en) Process for the production of liquid nitric acid esters of polyhydric alcohols
DE1116867B (en) Process for the production of a rectal capsule coating

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee